Market Insight - Microdosing reaching a tipping point?
This article was originally published in Scrip
Executive Summary
Advocates of microdosing, a technique that involves testing very small doses of products in humans, think it will improve the efficiency of drug development by flagging at an early stage those product candidates that are likely to fail. So why has it yet to enter the mainstream, asks Phil Greenfield